You have 9 free searches left this month | for more free features.

PIDD

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • HYQVIA
  • (no location specified)
Feb 23, 2023

Primary Immune Deficiency Trial (Asceniv™)

Recruiting
  • Primary Immune Deficiency
  • Asceniv™
  • Centennial, Colorado
  • +2 more
Sep 13, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

COVID-19 Vaccine Responses in PIDD Subjects

Recruiting
  • X-linked Agammaglobulinemia
  • +6 more
    • Saint Petersburg, Florida
    • +2 more
    Apr 7, 2022

    Primary Immune Deficiency Disorders (PIDD) Trial in United States (Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%])

    Completed
    • Primary Immune Deficiency Disorders (PIDD)
    • Nabi-IGIV 10% [Immune Globulin Intravenous (Human). 10%]
    • Birmingham, Alabama
    • +16 more
    Jul 28, 2021

    Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Infusion (Human), 10%, Recombinant human

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Infusion (Human), 10%
    • Recombinant human hyaluronidase
    • Irvine, California
    • +9 more
    Apr 30, 2021

    Primary Immunodeficiency Diseases (PID) Trial in United States (HYQVIA, GAMMAGARD LIQUID)

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • HYQVIA
    • GAMMAGARD LIQUID
    • Birmingham, Alabama
    • +18 more
    Sep 28, 2022

    Primary Immunodeficiency Diseases (PID) Trial in Canada, United States (Immune Globulin Intravenous (Human), 10% Solution,

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Intravenous (Human), 10% Solution
    • Immune Globulin Subcutaneous (Human), 20% Solution
    • Irvine, California
    • +17 more
    Jun 30, 2021

    Intestinal Inflammation in People With Primary Immune

    Recruiting
    • Chronic Granulomatous Disease
    • Inflammatory Bowel Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Primary Immune Deficiency Diseases (PIDD) Trial in Canada, United States (10% IGIV)

      Unknown status
      • Primary Immune Deficiency Diseases (PIDD)
      • 10% IGIV
      • Los Angeles, California
      • +11 more
      May 6, 2020

      5% Treatment Naïve Intravenous Immunoglobulin Primary

      Completed
      • Primary Immunodeficiency Disease (PIDD)
        • Newport Beach, California
        • +3 more
        Aug 6, 2019

        Primary Immunodeficiency Trial in United States (Immune Globulin Intravenous, Prometic's Immune Globulin Intravenous 10%)

        Completed
        • Primary Immunodeficiency
        • Immune Globulin Intravenous
        • Prometic's Immune Globulin Intravenous 10%
        • Irvine, California
        • +12 more
        Nov 3, 2021

        Participation in a Research Registry for Immune Disorders

        Recruiting
        • Primary Immunodeficiencies
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Apr 7, 2022

          Refractory Viral Infections Trial in Washington (mCTLs)

          Completed
          • Refractory Viral Infections
          • mCTLs
          • Washington, District of Columbia
            Childrens National Medical Center
          Jan 15, 2020

          Database for Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

          Terminated
          • Primary Immune Deficiency Disorder
          • Immunoglobulin Therapy
          • Lenexa, Kansas
            BriovaRx Infusion Services
          Aug 5, 2019

          Primary Immune Deficiency Disorder Trial in Kuwait

          Completed
          • Primary Immune Deficiency Disorder
            • Kuwait, Kuwait
              Pediatric Deprtmemt, Alsabah hospital
            Sep 5, 2019

            Octagam 5% Versus Comparator Post Marketing Trial

            Completed
            • Primary Immune Deficiency Disorder
            • Octagam 5%
            • Other marketed IVIG product
            • Granada Hills, California
            • +26 more
            Jun 7, 2019

            Asthma Trial in London (Self management education)

            Completed
            • Asthma
            • Self management education
            • London, United Kingdom
              NHLI at Charing Cross Hospital Campus
            Jan 17, 2020

            Primary Immune Deficiency Disorder Trial in United States (RI-002)

            Completed
            • Primary Immune Deficiency Disorder
            • RI-002
            • Cenntennial, Colorado
            • +8 more
            Aug 10, 2016

            Construction ofHealth-related Quality of Life Questionnaire for

            Completed
            • Immune Deficiency, Antibody
            • questionnaire survey
            • (no location specified)
            Jan 12, 2017

            Primary Immune Deficiency Diseases Trial in St. Petersburg (Bacteriophage OX174)

            Unknown status
            • Primary Immune Deficiency Diseases
            • Bacteriophage OX174
            • St. Petersburg, Florida
              University of South Florida
            Jul 16, 2012

            Primary Immunodeficiency Disorders Trial in St. Petersburg (Hizentra)

            Unknown status
            • Primary Immunodeficiency Disorders
            • St. Petersburg, Florida
              University of South Florida
            Jul 16, 2012